Horizon / Plein textes La base de ressources documentaires de l'IRD

IRD

 

Publications des scientifiques de l'IRD

Gabillard D., Lewden C., Ndoye I., Moh R., Segeral O., Tonwe-Gold B., Etard Jean-François, Pagnaroat M., Fournier-Nicolle I., Eholie S., Konate I., Minga A., Mpoudi-Ngole E., Koulla-Shiro S., Zannou D. M., Anglaret X., Laurent Christian. (2013). Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia : data from the ANRS 12222 collaboration. Jaids.Journal of Acquired Immune Deficiency Syndromes, 62 (5), 555-561. ISSN 1525-4135

Accès réservé (Intranet IRD) Demander le PDF

Lien direct chez l'éditeur doi:10.1097/QAI.0b013e3182821821

Titre
Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia : data from the ANRS 12222 collaboration
Année de publication2013
Type de documentArticle référencé dans le Web of Science WOS:000319111800020
AuteursGabillard D., Lewden C., Ndoye I., Moh R., Segeral O., Tonwe-Gold B., Etard Jean-François, Pagnaroat M., Fournier-Nicolle I., Eholie S., Konate I., Minga A., Mpoudi-Ngole E., Koulla-Shiro S., Zannou D. M., Anglaret X., Laurent Christian.
SourceJaids.Journal of Acquired Immune Deficiency Syndromes, 2013, 62 (5), p. 555-561. ISSN 1525-4135
RésuméBackground: In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness of care and treatment programmes, identify program weaknesses, and inform decisions. Methods: We pooled data from 13 research cohorts in 5 sub-Saharan African (Benin, Burkina Faso, Cameroon, Cote d'Ivoire, and Senegal) and 2 Asian (Cambodia and Laos) countries. HIV-infected adults (18 years and older) who received ART in 1998-2008 and had at least one CD4 count available were eligible. Changes in CD4 counts over time were estimated by a linear mixed regression. CD4-specific incidence rates were estimated as the number of first events occurring in a given CD4 stratum divided by the time spent within the stratum. Results: Overall 3917 adults (62% women) on ART were followed up during 10,154 person-years. In the <= 50, 51-100, 101-200, 201-350, 351-500, 501-650, and.650 cells/mm(3) CD4 cells strata, death rates were 20.6, 11.8, 6.7, 3.3, 1.8, 0.9, and 0.3 per 100 person-years; AIDS rates were 50.5, 32.9, 11.5, 4.8, 2.8, 2.2, and 2.2 per 100 person-years; and loss-to-follow-up rates were 4.9, 6.1, 3.5, 3.1, 2.9, 1.7, and 1.2 per 100 person-years, respectively. Mortality and morbidity were higher during the first year after ART initiation. Conclusions: In these resource-limited settings, death and AIDS rates remained substantial after ART initiation, even in individuals with high CD4 cell counts. Ensuring earlier ART initiation and optimizing case finding and treatment for AIDS-defining diseases should be seen as priorities.
Plan de classementEntomologie médicale / Parasitologie / Virologie [052] ; Santé : généralités [050]
Descr. géo.AFRIQUE ; ASIE
LocalisationFonds IRD [F B010060382]
Identifiant IRDfdi:010060382
Lien permanenthttp://www.documentation.ird.fr/hor/fdi:010060382

Export des données

Disponibilité des documents

Télechargment fichier PDF téléchargeable

Lien sur le Web lien chez l'éditeur

Accès réservé en accès réservé

HAL en libre accès sur HAL


Accès aux documents originaux :

Le FDI est labellisé CollEx

Accès direct

Bureau du chercheur

Site de la documentation

Espace intranet IST (accès réservé)

Suivi des publications IRD (accès réservé)

Mentions légales

Services Horizon

Poser une question

Consulter l'aide en ligne

Déposer une publication (accès réservé)

S'abonner au flux RSS

Voir les tableaux chronologiques et thématiques

Centres de documentation

Bondy

Montpellier (centre IRD)

Montpellier (MSE)

Cayenne

Nouméa

Papeete

Abidjan

Dakar

Niamey

Ouagadougou

Tunis

La Paz

Quito